Bio-Techne Corp (TECH)
75.63
+2.20
(+3.00%)
USD |
NASDAQ |
May 02, 16:00
75.63
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Cash from Financing (Quarterly): -81.40M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -81.40M |
| September 30, 2023 | 71.51M |
| June 30, 2023 | -24.22M |
| March 31, 2023 | 150.84M |
| December 31, 2022 | -72.20M |
| September 30, 2022 | -31.81M |
| June 30, 2022 | -65.73M |
| March 31, 2022 | -84.06M |
| December 31, 2021 | -53.38M |
| September 30, 2021 | -39.68M |
| June 30, 2021 | 117.69M |
| March 31, 2021 | -55.23M |
| December 31, 2020 | -90.08M |
| September 30, 2020 | -34.93M |
| June 30, 2020 | -44.72M |
| March 31, 2020 | -17.79M |
| December 31, 2019 | -97.03M |
| September 30, 2019 | -24.27M |
| June 30, 2019 | -19.90M |
| March 31, 2019 | -27.04M |
| December 31, 2018 | -41.21M |
| September 30, 2018 | 222.53M |
| June 30, 2018 | -62.83M |
| March 31, 2018 | -0.952M |
| December 31, 2017 | 15.55M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.95M |
| June 30, 2017 | -16.64M |
| March 31, 2017 | -24.52M |
| December 31, 2016 | -11.88M |
| September 30, 2016 | 242.16M |
| June 30, 2016 | -32.33M |
| March 31, 2016 | -19.54M |
| December 31, 2015 | -13.37M |
| September 30, 2015 | 41.86M |
| June 30, 2015 | -85.68M |
| March 31, 2015 | -11.00M |
| December 31, 2014 | 25.48M |
| September 30, 2014 | 102.47M |
| June 30, 2014 | -8.009M |
| March 31, 2014 | -9.912M |
| December 31, 2013 | -8.983M |
| September 30, 2013 | -9.902M |
| June 30, 2013 | -12.58M |
| March 31, 2013 | -11.05M |
| December 31, 2012 | -10.30M |
| September 30, 2012 | -10.75M |
| June 30, 2012 | -12.45M |
| March 31, 2012 | -13.20M |
| December 31, 2011 | -17.43M |
| September 30, 2011 | -21.56M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-97.03M
Minimum
Dec 2019
150.84M
Maximum
Mar 2023
-26.12M
Average
-39.68M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Agilent Technologies Inc | -240.00M |
| Bio-Rad Laboratories Inc | -200.62M |
| Revvity Inc | -35.01M |
| Twist Bioscience Corp | -1.473M |
| AIM ImmunoTech Inc | 0.147M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 83.12M |
| Cash from Investing (Quarterly) | -23.67M |
| Free Cash Flow | 225.39M |
| Free Cash Flow Per Share (Quarterly) | 0.4264 |
| Free Cash Flow to Equity (Quarterly) | 61.25M |
| Free Cash Flow to Firm (Quarterly) | 71.14M |
| Free Cash Flow Yield | 1.85% |